We are live on ! Find out more
CP

Catalys Pacific Portfolio holdings

AUM $229M
1-Year Est. Return 100.3%
This Fund
S&P 500
This Quarter Est. Return
-2.99%
1 Year Est. Return
+100.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$116M
AUM Growth
-$9.51M
Cap. Flow
+$136K
Cap. Flow %
0.12%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$552K

Top Sells

Rank Stock Value
1
HLVX
HilleVax
HLVX
+$416K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLYS icon
1
Mineralys Therapeutics
MLYS
$2.34B
$106M 91.82%
8,644,579
– –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$679M
$9.48M 8.18%
1,167,114
+44,542
+4% +$552K
HLVX
3
DELISTED
HilleVax
HLVX
– –
-236,379
Closed -$416K

Similar funds

CCM
Cloud Capital Management Seattle, Washington $229M AUM 19.91% 1-Year Est. Return
CIS
Custom Index Systems New York $230M AUM 33.6% 1-Year Est. Return
CCP
Cane Capital Partners Saint Francisville, Louisiana $229M AUM
AIA
Alternative Investment Advisors Maitland, Florida $229M AUM 17.2% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
NIA
NBZ Investment Advisors Knoxville, Tennessee $229M AUM 17.28% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return
AF
Abound Financial Granite Bay, California $229M AUM 17.03% 1-Year Est. Return

Catalys Pacific's Q4 2024 Portfolio in Review

As of Q4 2024, Catalys Pacific held 3 positions worth $116M, down 7.6% from $125M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Catalys Pacific's Q4 2024 filing shows 1 increased and 1 closed positions. The largest sale was HilleVax, an estimated $416K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Catalys Pacific added most to Phathom Pharmaceuticals in Q4 2024, an estimated $552K increase.
  • Catalys Pacific fully exited HilleVax in Q4 2024, selling an estimated $416K.
  • Catalys Pacific's ten largest holdings make up 100% of its $116M portfolio in Q4 2024.
  • Catalys Pacific opened 0 new positions and closed 1 in Q4 2024.
  • Catalys Pacific's portfolio value fell 7.6% quarter-over-quarter to $116M.

Based on Catalys Pacific's 13F filing for Q4 2024, filed 14 Feb 2025.